SE0302331D0 - New use II - Google Patents

New use II

Info

Publication number
SE0302331D0
SE0302331D0 SE0302331A SE0302331A SE0302331D0 SE 0302331 D0 SE0302331 D0 SE 0302331D0 SE 0302331 A SE0302331 A SE 0302331A SE 0302331 A SE0302331 A SE 0302331A SE 0302331 D0 SE0302331 D0 SE 0302331D0
Authority
SE
Sweden
Prior art keywords
new use
angiotensin
prevention
type
myocardial infarction
Prior art date
Application number
SE0302331A
Other languages
English (en)
Swedish (sv)
Inventor
John Mcmurray
Jan Oestergren
Marc A Pfeffer
Karl Swedberg
Christopher B Granger
Salim Yusuf
Peter Held
Eric L Michelson
Bertil Olofsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302331A priority Critical patent/SE0302331D0/xx
Publication of SE0302331D0 publication Critical patent/SE0302331D0/xx
Priority to PCT/SE2004/001228 priority patent/WO2005020971A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SE0302331A 2003-08-29 2003-08-29 New use II SE0302331D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0302331A SE0302331D0 (sv) 2003-08-29 2003-08-29 New use II
PCT/SE2004/001228 WO2005020971A1 (en) 2003-08-29 2004-08-25 Use of an angiotensin ii antagonist for the prevention of myocardial infarction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302331A SE0302331D0 (sv) 2003-08-29 2003-08-29 New use II

Publications (1)

Publication Number Publication Date
SE0302331D0 true SE0302331D0 (sv) 2003-08-29

Family

ID=28673224

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302331A SE0302331D0 (sv) 2003-08-29 2003-08-29 New use II

Country Status (2)

Country Link
SE (1) SE0302331D0 (xx)
WO (1) WO2005020971A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246742B1 (es) * 2005-09-06 2007-02-01 Prous Institute For Biomedical Research S.A. Uso de un derivado de imidazol.
EP2350031A2 (en) 2008-08-20 2011-08-03 Ensemble Therapeutics Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
US10111747B2 (en) 2013-05-20 2018-10-30 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
CN117607311B (zh) * 2024-01-19 2024-03-29 地奥集团成都药业股份有限公司 一种盐酸贝那普利对映异构体的检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0007686A (pt) * 1999-01-26 2001-11-06 Novartis Ag Uso de antagonistas receptores da angiotensina ii para tratar enfartação miocárdia aguda
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination

Also Published As

Publication number Publication date
WO2005020971A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
WO2006128184A3 (en) Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
ATE478664T1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
UA93351C2 (xx) Похідні фталазіну як інгібітори parp$производные фталазина kak ингибиторы parp
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
JO3492B1 (ar) تركيبات صيدلانية من مضاد مستقبل أنجيوتنسين ومثبط nep
NO20052378D0 (no) Pre-organiserte trisykliske integraseinhibitorforbindelser
DE602005014382D1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb-kinaseinhibitoren
HUP0301841A2 (hu) Kardiovaszkuláris betegségek gyógyítására alkalmas renin inhibitort tartalmazó szinergetikus hatású kombinációs készítmények és alkalmazásuk
ATE400567T1 (de) Kinaseinhibitoren
TW200612950A (en) Quinazolinedione derivatives as PARP inhibitors
MX2008014873A (es) Inhibidores de metaloproteasa heterobiciclicas.
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
WO2003065987A3 (en) Granzyme b inhibitors
TR201907381T4 (tr) Beta-laktamil fenilalanin, sistein ve serin vazopressin antagonisti.
MY143516A (en) Kinase inhibitors
IL163777A0 (en) Kinase inhibitors
WO2002015891A3 (en) Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
ATE438398T1 (de) Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren
DE60313350D1 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
TW200507855A (en) Combination of an aldosterone receptor antagonist and a neutral endopeptidase inhibitor
DE60215368D1 (de) Pyranderivate als inhibitoren von ace und nep
MXPA05009282A (es) Derivados de anilina sustituidos.
ATE443044T1 (de) Tace inhibitoren